Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Completed · Phase 2
Conditions studied: Parkinson's Disease
In brief
The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.
Key facts
- Study ID
- NCT00623363
- Run by
- Daiichi Sankyo
- People needed
- 27
- Starts
- 2007-07-13
- Expected to finish
- 2008-07-17
- Last updated by the study team
- 2021-03-11
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Parkinson's and Movement Disorder Institute — Fountain Valley, California, United States
- University of South Florida, Parkinson's Disease and Movement Disorders Center — Tampa, Florida, United States
- Emory University--Wesley Woods Health Center — Atlanta, Georgia, United States
- UMDNJ-Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
- Suny Downstate Medical Center — Brooklyn, New York, United States
- Hospital Multimedica — Guatemala City, Guatemala
- Hospital Clinic of Neurology and Psychiatry Oradea — Oradea, Romania
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.